Sulfonyl aryl or heteroaryl hydroxamic acid compounds
Number of patents in Portfolio can not be more than 2000
United States of America Patent
Stats
-
Oct 3, 2006
Issued Date -
N/A
app pub date -
May 11, 2000
filing date -
May 12, 1999
priority date (Note) -
Expired
status (Latency Note)
Importance
Abstract
A sulfonyl aromatic or heteroaromatic ring hydroxamic acid compound that inter alia inhibits matrix metalloprotease activity is disclosed as are a treatment process that comprises administering a contemplated sulfonyl aromatic or heteroaromatic ring hydroxamic acid compound in a MMP enzyme-inhibiting effective amount to a host having a condition associated with pathological matrix metalloprotease activity. A contemplated compound corresponds in structure to the formula ##STR00001## wherein W and the R groups are defined elsewhere.
First Claim
Family
International Classification(s)
Cited Art Landscape
Patent Citation Ranking
Advertisement
Advertisement
Advertisement
Recipient Email Address
Recipient Email Address
Comment
Recipient Email Address
Add to Portfolio(s)
To add this patent to one, or more, of your portfolios, simply click the add button.
This Patent is in these Portfolios:
Add to additional portfolios:
Last Refreshed On:
Changes done successfully